MicrobiologybioRxivPreprint
Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses
Dennis Salomon Lopez Molina, Nazim Ahnou, Rozenn Brillet…·Abdelhakim Ahmed‐Belkacem
This study identifies CK2 as a critical host factor for SARS-CoV-2 replication and shows that the bivalent inhibitor AB668 effectively inhibits multiple coronaviruses.
DOI 10.64898/2026.10.05.756735